Clinicopathological data's of advanced NSCLC patients with ROS1 gene rearrangement and of clinical responses to crizotinib in Turkey
| dc.contributor.author | Öz, Buge | |
| dc.contributor.author | Batur, Şebnem | |
| dc.contributor.author | Eralp, Yeşim | |
| dc.contributor.author | Hastürk, Serap | |
| dc.contributor.author | Yumuk, Fulden | |
| dc.contributor.author | Yıldız, Özcan | |
| dc.contributor.author | Karaoğlu, Aziz | |
| dc.date.accessioned | 10.07.201910:49:13 | |
| dc.date.accessioned | 2019-07-10T20:01:34Z | |
| dc.date.available | 10.07.201910:49:13 | |
| dc.date.available | 2019-07-10T20:01:34Z | |
| dc.date.issued | 2015 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | |
| dc.description | WOS: 000370365103329 | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.citation | Öz, B., Batur, Ş., Eralp, Y., Hastürk, S., Yumuk, F., Yıldız, Ö. ve Karaoğlu, A. (2015). Clinicopathological data's of advanced NSCLC patients with ROS1 gene rearrangement and of clinical responses to crizotinib in Turkey. Journal of Thoracic Oncology içinde (S695-S695. ss.). Elsevier Science. | |
| dc.identifier.endpage | S695 | |
| dc.identifier.issn | 1556-0864 | |
| dc.identifier.issn | 1556-1380 | |
| dc.identifier.issue | 9 | |
| dc.identifier.startpage | S695 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/3345 | |
| dc.identifier.volume | 10 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Science | |
| dc.relation.ispartof | Journal of Thoracic Oncology | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Ros1 Rearrangement | |
| dc.subject | Nonsmall Cell Lung Cancer | |
| dc.subject | Crizotinib Treatment | |
| dc.title | Clinicopathological data's of advanced NSCLC patients with ROS1 gene rearrangement and of clinical responses to crizotinib in Turkey | |
| dc.type | Conference Object |











